-We reported impaired endotheliumderived relaxation factor/nitric oxide (EDRF/NO) responses and constitutive nitric oxide synthase (cNOS) activity in subcutaneous vessels dissected from patients with essential hypertension (n ϭ 9) compared with normal controls (n ϭ 10). We now test the hypothesis that the patients in this study have increased circulating levels of the cNOS inhibitor, asymmetric dimethylarginine (ADMA), or the lipid peroxidation product of linoleic acid, 13-hydroxyoctadecadienoic acid (HODE), which is a marker of reactive oxygen species. Patients had significantly (P Ͻ 0.001) elevated (means Ϯ SD) plasma levels of ADMA (P ADMA, 766 Ϯ 217 vs. 393 Ϯ 57 nmol/l) and symmetric dimethylarginine (P SDMA: 644 Ϯ 140 vs. 399 Ϯ 70 nmol/l) but similar levels of L-arginine accompanied by significantly (P Ͻ 0.015) increased rates of renal ADMA excretion (21 Ϯ 9 vs. 14 Ϯ 5 nmol/ mol creatinine) and decreased rates of renal ADMA clearance (18 Ϯ 3 vs. 28 Ϯ 5 ml/min). They had significantly increased plasma levels of HODE (P HODE: 309 Ϯ 30 vs. 226 Ϯ 24 nmol/l) and renal HODE excretion (433 Ϯ 93 vs. 299 Ϯ 67 nmol/mol creatinine). For the combined group of normal and hypertensive subjects, the individual values for plasma levels of ADMA and HODE were both significantly (P Ͻ 0.001) and inversely correlated with microvascular EDRF/NO and positively correlated with mean blood pressure. In conclusion, elevated levels of ADMA and oxidative stress in a group of hypertensive patients could contribute to the associated microvascular endothelial dysfunction and elevated blood pressure. blood pressure; 13-hydroxyoctadecadienoic acid; endothelium-derived relaxation factor/nitric oxide; albuminuria MOST OF THE ESTABLISHED AND nontraditional cardiovascular risk factors are associated with endothelial dysfunction (3,5,7,18,45). This includes those with essential hypertension in some (29,33,34,35,39,42,50), but not all, studies (54). Endothelial function depends on the integrity of constitutive nitric oxide synthase (cNOS) and the availability and vascular signaling of its product, nitric oxide (NO). Endothelial dysfunction is of clinical importance since it predisposes to the development of hypertension and atherosclerosis and consequently is a predictor of subsequent adverse cardiovascular events (34).Endothelial dysfunction has been ascribed to two principal factors. One is an enhanced vascular generation of superoxide anion (O 2 ⅐ Ϫ ) that bioinactivates endothelial-derived NO (5), thereby reducing endothelial function and forming peroxynitrite (ONOO Ϫ ). Peroxynitrite itself can nitrosate and inactivate prostacyclin synthase (46), which is an additional pathway mediating endothelium-dependent relaxation. A second factor is generation of asymmetric dimethylarginine (ADMA), which inhibits nitric oxide synthase (6) and inhibits the cellular uptake of L-arginine by the cationic amino acid transporters (CATs) (8).We have studied endothelial function and cNOS activity directly in subcutaneous resistance vessels dissected from glute...